Impaired quality of life in patients with systemic sclerosis compared to the general population and chronic dermatoses

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Bretterklieber, Agnes ^a   Painsi, Clemens ^a,b   Avian, Alexander ^a   Wutte, Nora ^a   Aberer, Elisabeth ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b GENERAL HOSPITAL KLAGENFURT   (Austria)

Author keywords

Chronic skin disease; Lupus erythematosus; Quality of life; SF 36; Systemic sclerosis

Indexed keywords

AGED; CASE CONTROL STUDY; CHRONIC DISEASE; COMPARATIVE STUDY; COST OF ILLNESS; EMOTION; FEMALE; HEALTH STATUS; HUMAN; MALE; MENTAL HEALTH; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PROGNOSIS; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; SCLERODERMA, SYSTEMIC; SKIN DISEASES; SOCIAL BEHAVIOR;

AGED; CASE-CONTROL STUDIES; CHRONIC DISEASE; COST OF ILLNESS; EMOTIONS; FEMALE; HEALTH STATUS; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; SCLERODERMA, SYSTEMIC; SKIN DISEASES; SOCIAL BEHAVIOR;

EID: 84908268041     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-594     Document Type: Article

References (40)

1. Scleroderma. Gabrielli A, Avvedimento EV, Krieg T, N Engl J Med 2009 360 1989 2003 10.1056/NEJMra0806188 19420368
2. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommetee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Commettee. Arthritis Rheum 1980 23 581 590 10.1002/art.1780230510 7378088
3. Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions. Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M, J Rheumatol 2009 36 768 772 10.3899/jrheum.080281 19228662
4. Effect of Biologic Agents on Non-PASI Outcomes in Moderate-to-Severe Plaque Psoriasis: Systematic Review and Meta-Analyses. Baker EL, Coleman CI, Reinhart KM, Phung OJ, Kugelman L, Chen W, White CM, Mamolo CM, Cappelleri JC, Baker WL, Dermatol Ther (Heidelb) 2012 2 9 23205332
5. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. McHorney CA, Ware JE Jr, Raczek AE, Med Care 1993 31 247 263 10.1097/00005650-199303000-00006 8450681
6. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Ware JE Jr, Sherbourne CD, Med Care 1992 30 473 483 10.1097/00005650-199206000-00002 1593914
7. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases. Johnson SR, Glaman DD, Schentag CT, Lee P, J Rheumatol 2006 33 1117 1122 16622903
8. Clinical correlates of self-reported physical health status in systemic sclerosis. Hudson M, Steele R, Lu Y, Thombs BD, Panopalis P, Baron M, J Rheumatol 2009 36 1226 1229 10.3899/jrheum.081057 19447939
9. Health-related quality of life in systemic sclerosis: a systematic review. Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M, Arthritis Rheum 2009 61 1112 1120 10.1002/art.24676 19644906
10. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey. Rannou F, Poiraudeau S, Berezne A, Baubet T, Le-Guern V, Cabane J, Guillevin L, Revel M, Fermanian J, Mouthon L, Arthritis Rheum 2007 57 94 102 10.1002/art.22468 17266096
11. The scleroderma Assessment Questionnaire (SAQ). A new self-assessment questionnaire for evaluation of disease status in patients with systemic sclerosis. Ostojic P, Damjanov N, Z Rheumatol 2006 65 168 175 10.1007/s00393-006-0050-7 16501926
12. Quality of life as measured by the short-form 36 (SF-36) questionnaire in patients with early systemic sclerosis and undifferentiated connective tissue disease. Iudici M, Cuomo G, Vettori S, Avellino M, Valentini G, Health Qual Life Outcomes 2013 11 23 10.1186/1477-7525-11-23 23442975
13. Differences in patients with systemic sclerosis recruited from associations and tertiary care settings. Mestre-Stanislas C, Poiraudeau S, Berezne A, Rannou F, Pagnoux C, Revel M, Guillevin L, Mouthon L, Presse Med 2010 39 205 e209 10.1016/j.lpm.2010.02.038 20356709
14. Bullinger MKI, SF-36 Fragebogen zum Gesundheitszustand Göttingen, Bern, Toronto, Seattle: Hogrefe-Verlag GmbH & Co, Verlag für Psychologie 1998
15. Disease severity and quality of life in a follow-up study of patients with occupational contact dermatitis. Lau MY, Matheson MC, Burgess JA, Dharmage SC, Nixon R, Contact Dermatitis 2011 65 138 145 10.1111/j.1600-0536.2011.01896.x 21722138
16. Health-related quality of life among patients with ichthyosis. Ganemo A, Sjoden PO, Johansson E, Vahlquist A, Lindberg M, Eur J Dermatol 2004 14 61 66 14965800
17. Quality of life assessment in nonmelanoma cervicofacial skin cancer. Rhee JS, Loberiza FR, Matthews BA, Neuburg M, Smith TL, Burzynski M, Laryngoscope 2003 113 215 220 10.1097/00005537-200302000-00004 12567071
18. Eczema: quality of life by body site and the effect of patch testing. Thomson KF, Wilkinson SM, Sommer S, Pollock B, Br J Dermatol 2002 146 627 630 10.1046/j.1365-2133.2002.04692.x 11966694
19. Life quality assessment among patients with atopic eczema. Holm EA, Wulf HC, Stegmann H, Jemec GB, Br J Dermatol 2006 154 719 725 10.1111/j.1365-2133.2005.07050.x 16536816
20. Health-related quality of life and nail disorders. Tabolli S, Alessandroni L, Gaido J, Sampogna F, Di Pietro C, Abeni D, Acta Derm Venereol 2007 87 255 259 17533493
21. Health-related quality of life and marital quality of vitiligo patients in China. Wang KY, Wang KH, Zhang ZP, J Eur Acad Dermatol Venereol 2011 25 429 435 10.1111/j.1468-3083.2010.03808.x 20666878
22. Health-related quality of life in health care workers with work-related skin diseases. Matterne U, Apfelbacher CJ, Soder S, Diepgen TL, Weisshaar E, Contact Dermatitis 2009 61 145 151 10.1111/j.1600-0536.2009.01592.x 19780772
23. Health-related quality of life in patients with atopic dermatitis. Maksimovic N, Jankovic S, Marinkovic J, Sekulovic LK, Zivkovic Z, Spiric VT, J Dermatol 2012 39 42 47 10.1111/j.1346-8138.2011.01295.x 22044078
24. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36. Sampogna F, Tabolli S, Soderfeldt B, Axtelius B, Aparo U, Abeni D, Br J Dermatol 2006 154 844 849 10.1111/j.1365-2133.2005.07071.x 16634884
25. The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire. Tabolli S, Mozzetta A, Antinone V, Alfani S, Cianchini G, Abeni D, Br J Dermatol 2008 158 1029 1034 10.1111/j.1365-2133.2008.08481.x 18294312
26. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses? Jolly M, J Rheumatol 2005 32 1706 1708 16142864
27. Health-related quality of life in primary Raynaud phenomenon. De Angelis R, Salaffi F, Grassi W, J Clin Rheumatol 2008 14 206 210 10.1097/RHU.0b013e31817a2485 18766120
28. Comparison of pain, pain burden, coping strategies, and attitudes between patients with systemic sclerosis and patients with rheumatoid arthritis: a cross-sectional study. Perrot S, Dieude P, Perocheau D, Allanore Y, Pain Med 2013 14 1776 1785 10.1111/pme.12213 23899271
29. Clinical, functional and health-related quality of life correlates of clinically significant symptoms of anxiety and depression in patients with systemic sclerosis: a cross-sectional survey. Nguyen C, Ranque B, Baubet T, Berezne A, Mestre-Stanislas C, Rannou F, Papelard A, Morell-Dubois S, Revel M, Moro MR, Guillevin L, Poiraudeau S, Mouthon L, Groupe Français de Recherche sur la Sclérodermie, PLoS One 2014 9 90484 10.1371/journal.pone.0090484 24587375
30. Disease and symptom burden in systemic sclerosis: a patient perspective. Suarez-Almazor ME, Kallen MA, Roundtree AK, Mayes M, J Rheumatol 2007 34 1718 1726 17611983
31. Life with a rare chronic disease: the scleroderma experience. Joachim G, Acorn S, J Adv Nurs 2003 42 598 606 10.1046/j.1365-2648.2003.02663.x 12787233
32. Concepts of functioning and health important to people with systemic sclerosis: a qualitative study in four European countries. Stamm TA, Mattsson M, Mihai C, Stocker J, Binder A, Bauernfeind B, Stummvoll G, Gard G, Hesselstrand R, Sandqvist G, Draghicescu O, Gherghe AM, Voicu M, Machold KP, Distler O, Smolen JS, Boström C, Ann Rheum Dis 2011 70 1074 1079 10.1136/ard.2010.148767 21540204
33. The psychosocial impact of skin disease. An overview. Ginsburg IH, Dermatol Clin 1996 14 473 484 10.1016/S0733-8635(05)70375-2 8818557
34. Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. Duruoz MT, Poiraudeau S, Fermanian J, Menkes CJ, Amor B, Dougados M, Revel M, J Rheumatol 1996 23 1167 1172 8823687
35. Addressing patient health care demands in systemic sclerosis: pre-post assessment of a psycho-educational group programme. Kwakkenbos L, Bluyssen SJ, Vonk MC, van Helmond AF, van den Ende CH, van den Hoogen FH, van Lankveld WG, Clin Exp Rheumatol 2011 29 60 S65
36. Mental health in patients with systemic sclerosis: a controlled investigation. Mozzetta A, Antinone V, Alfani S, Neri P, Foglio Bonda PG, Pasquini P, Puddu P, Picardi A, J Eur Acad Dermatol Venereol 2008 22 336 340 10.1111/j.1468-3083.2007.02426.x 18269602
37. Spiritual Coping and Adjustment in Adolescents With Chronic Illness: A 2-Year Prospective Study. Reynolds N, Mrug S, Hensler M, Guion K, Madan-Swain A, J Pediatr Psychol 2014 39 542 551 10.1093/jpepsy/jsu011 24648256
38. Spiritual needs among patients with chronic pain diseases and cancer living in a secular society. Bussing A, Janko A, Baumann K, Hvidt NC, Kopf A, Pain Med 2013 14 1362 1373 10.1111/pme.12198 23870113
39. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, Goulet JR, Rich E, Grodzicky T, Raymond Y, Senecal JL, Arthritis Rheum 2008 58 3902 3912 10.1002/art.24038 19035499
40. Adjusting for multiple testing-when and how? Bender R, Lange S, J Clin Epidemiol 2001 54 343 349 10.1016/S0895-4356(00)00314-0 11297884